Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103


Analysis of antibody response (IgM, IgG, IgG3) to Chikungunya virus using panel of peptides derived from envelope protein for serodiagnosis.

Verma P, Bhatnagar S, Kumar P, Chattree V, Parida MM, Hoti SL, Ali S, Rao DN.

Clin Chem Lab Med. 2014 Feb;52(2):297-307. doi: 10.1515/cclm-2013-0363.


Expression and evaluation of Chikungunya virus E1 and E2 envelope proteins for serodiagnosis of Chikungunya virus infection.

Cho B, Jeon BY, Kim J, Noh J, Kim J, Park M, Park S.

Yonsei Med J. 2008 Oct 31;49(5):828-35. doi: 10.3349/ymj.2008.49.5.828.


Development and evaluation of baculovirus-expressed Chikungunya virus E1 envelope proteins for serodiagnosis of Chikungunya infection.

Kumar P, Pok KY, Tan LK, Angela C, Leo YS, Ng LC.

J Virol Methods. 2014 Sep;206:67-75. doi: 10.1016/j.jviromet.2014.05.014.


A potent neutralizing IgM mAb targeting the N218 epitope on E2 protein protects against Chikungunya virus pathogenesis.

Lam S, Nyo M, Phuektes P, Yew CW, Tan YJ, Chu JJ.

MAbs. 2015;7(6):1178-94. doi: 10.1080/19420862.2015.1083664.


Evaluation of Chikungunya diagnostic assays: differences in sensitivity of serology assays in two independent outbreaks.

Yap G, Pok KY, Lai YL, Hapuarachchi HC, Chow A, Leo YS, Tan LK, Ng LC.

PLoS Negl Trop Dis. 2010 Jul 20;4(7):e753. doi: 10.1371/journal.pntd.0000753.


Diagnosis of Chikungunya fever in an Indian population by an indirect enzyme-linked immunosorbent assay protocol based on an antigen detection assay: a prospective cohort study.

Kashyap RS, Morey SH, Ramteke SS, Chandak NH, Parida M, Deshpande PS, Purohit HJ, Taori GM, Daginawala HF.

Clin Vaccine Immunol. 2010 Feb;17(2):291-7. doi: 10.1128/CVI.00326-09.


Evaluation of multiple antigenic peptides based on the Chikungunya E2 protein for improved serological diagnosis of infection.

Bhatnagar S, Kumar P, Mohan T, Verma P, Parida MM, Hoti SL, Rao DN.

Viral Immunol. 2015 Mar;28(2):107-12. doi: 10.1089/vim.2014.0031.


Comparative evaluation of the diagnostic potential of recombinant envelope proteins and native cell culture purified viral antigens of Chikungunya virus.

Khan M, Dhanwani R, Kumar JS, Rao PV, Parida M.

J Med Virol. 2014 Jul;86(7):1169-75. doi: 10.1002/jmv.23752.


Exposure of epitope residues on the outer face of the chikungunya virus envelope trimer determines antibody neutralizing efficacy.

Fong RH, Banik SS, Mattia K, Barnes T, Tucker D, Liss N, Lu K, Selvarajah S, Srinivasan S, Mabila M, Miller A, Muench MO, Michault A, Rucker JB, Paes C, Simmons G, Kahle KM, Doranz BJ.

J Virol. 2014 Dec;88(24):14364-79. doi: 10.1128/JVI.01943-14.


A small antigenic determinant of the Chikungunya virus E2 protein is sufficient to induce neutralizing antibodies which are partially protective in mice.

Weber C, Büchner SM, Schnierle BS.

PLoS Negl Trop Dis. 2015 Apr 23;9(4):e0003684. doi: 10.1371/journal.pntd.0003684.


Chikungunya virus RNA and antibody testing at a National Reference Laboratory since the emergence of Chikungunya virus in the Americas.

Prince HE, Seaton BL, Matud JL, Batterman HJ.

Clin Vaccine Immunol. 2015 Mar;22(3):291-7. doi: 10.1128/CVI.00720-14.


Expression of the capsid protein of Chikungunya virus in a baculovirus for serodiagnosis of Chikungunya disease.

Cho B, Kim J, Cho JE, Jeon BY, Park S.

J Virol Methods. 2008 Dec;154(1-2):154-9. doi: 10.1016/j.jviromet.2008.07.031.


Early neutralizing IgG response to Chikungunya virus in infected patients targets a dominant linear epitope on the E2 glycoprotein.

Kam YW, Lum FM, Teo TH, Lee WW, Simarmata D, Harjanto S, Chua CL, Chan YF, Wee JK, Chow A, Lin RT, Leo YS, Le Grand R, Sam IC, Tong JC, Roques P, Wiesmüller KH, Rénia L, Rötzschke O, Ng LF.

EMBO Mol Med. 2012 Apr;4(4):330-43. doi: 10.1002/emmm.201200213.


[[Virus-like particle-based immunoglobulin M capture enzyme-linked immunosorbent assay for the detection of IgM antibodies against Chikungunya virus].

Li JD, Zhang QF, Zhang S, Li C, Liu QZ, Liang MF, Li DX.

Bing Du Xue Bao. 2014 Nov;30(6):599-604. Chinese.


Chikungunya virus with E1-A226V mutation causing two outbreaks in 2010, Guangdong, China.

Wu D, Zhang Y, Zhouhui Q, Kou J, Liang W, Zhang H, Monagin C, Zhang Q, Li W, Zhong H, He J, Li H, Cai S, Ke C, Lin J.

Virol J. 2013 Jun 2;10:174. doi: 10.1186/1743-422X-10-174.


Evaluation of the first commercial chikungunya virus indirect immunofluorescence test.

Litzba N, Schuffenecker I, Zeller H, Drosten C, Emmerich P, Charrel R, Kreher P, Niedrig M.

J Virol Methods. 2008 Apr;149(1):175-9. doi: 10.1016/j.jviromet.2008.01.004.


High rate of subclinical chikungunya virus infection and association of neutralizing antibody with protection in a prospective cohort in the Philippines.

Yoon IK, Alera MT, Lago CB, Tac-An IA, Villa D, Fernandez S, Thaisomboonsuk B, Klungthong C, Levy JW, Velasco JM, Roque VG Jr, Salje H, Macareo LR, Hermann LL, Nisalak A, Srikiatkhachorn A.

PLoS Negl Trop Dis. 2015 May 7;9(5):e0003764. doi: 10.1371/journal.pntd.0003764.


An approach towards peptide-based antibody detection for diagnosis of Chikungunya infection.

Morey SH, Kashyap RS, Purohit HJ, Taori GM, Daginawala HF.

Biomarkers. 2010 Sep;15(6):546-52. doi: 10.3109/1354750X.2010.494200.


Preparation of vesicular stomatitis virus pseudotype with Chikungunya virus envelope protein.

Tong W, Yin XX, Lee BJ, Li YG.

Acta Virol. 2015 Jun;59(2):189-93.


Cloning, expression and evaluation of diagnostic potential of recombinant capsid protein based IgM ELISA for chikungunya virus.

Priya R, Khan M, Rao MK, Parida M.

J Virol Methods. 2014 Jul;203:15-22. doi: 10.1016/j.jviromet.2014.03.005.

Items per page

Supplemental Content

Support Center